InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: elichen post# 99496

Monday, 03/24/2014 1:04:13 PM

Monday, March 24, 2014 1:04:13 PM

Post# of 403616
DJUSBT sell off due to

Biotech Continues Friday Sell-Off On Drug Pricing Concerns 03/24 12:17 PM

12:17 PM EDT, 03/24/2014 (MT Newswires) -- Biotechs continue to get slammed Monday, a second day of dramatic market reaction after Congress asked Gilead Sciences (GILD:$71.91,00$-0.16,00-0.22%) to justify pricing on the company's $1,000 hepatitis C pill, which has raised concerns for the impact on the Medicare and Medicaid programs.
In a Congressional letter sent Thursday, March 20, representatives told GILD that an expensive treatment will hurt patients who can not afford the medication. A response from GILD is requested by April 3.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News